{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:07:43Z","timestamp":1790734063659,"version":"4.1.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["201911FBD-433120-DRA-CEDA-251523"],"award-info":[{"award-number":["201911FBD-433120-DRA-CEDA-251523"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000241","name":"Physicians\u2019 Services Incorporated Foundation","doi-asserted-by":"publisher","award":["RT8-2021"],"award-info":[{"award-number":["RT8-2021"]}],"id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>Kidney homeostasis is highly dependent upon the correct functioning of myeloid cells. These cells form a distributed surveillance network throughout the kidney, where they play an integral role in the response to organ threat. Dysregulation of resident proinflammatory and profibrotic macrophages leads to kidney structural damage and scarring after kidney injury. Fibrosis throughout the kidney parenchyma contributes to the progressive functional decline observed in CKD, independent of the etiology. Circulating myeloid cells bearing intrinsic defects also affect the kidney substructures, such as neutrophils activated by autoantibodies that cause GN in ANCA-associated vasculitis. The kidney can also be affected by disorders of myelopoiesis, including myeloid leukemias (acute and chronic myeloid leukemias) and myelodysplastic syndromes. Clonal hematopoiesis of indeterminate potential is a common, newly recognized premalignant clinical entity characterized by clonal expansion of hyperinflammatory myeloid lineage cells that may have significant kidney sequelae. A number of existing therapies in CKD target myeloid cells and inflammation, including glucocorticoid receptor agonists and mineralocorticoid receptor antagonists. The therapeutic indications for these and other myeloid cell-targeted treatments is poised to expand as our understanding of the myeloid-kidney interface evolves.<\/jats:p>","DOI":"10.2215\/cjn.04120321","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T12:00:15Z","timestamp":1631275215000},"page":"323-331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["The Myeloid-Kidney Interface in Health and Disease"],"prefix":"10.2215","volume":"17","author":[{"given":"Caitlyn","family":"Vlasschaert","sequence":"first","affiliation":[{"name":"Department of Medicine, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-4133","authenticated-orcid":false,"given":"Sarah M.","family":"Moran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rauh","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2]]},"reference":[{"key":"B1-20250825","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1681\/ASN.2020060806","article-title":"Kidney single-cell atlas reveals myeloid heterogeneity in progression and regression of kidney disease","volume":"31","author":"Conway","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B2-20250825","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.aat5031","article-title":"Spatiotemporal immune zonation of the human kidney","volume":"365","author":"Stewart","year":"2019","journal-title":"Science"},{"key":"B3-20250825","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1681\/ASN.2018090896","article-title":"Single-cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease","volume":"30","author":"Fu","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B4-20250825","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2019.04.013","article-title":"The neutrophil life cycle","volume":"40","author":"Hidalgo","year":"2019","journal-title":"Trends Immunol"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: Nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B7-20250825","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: Versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B8-20250825","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41581-020-0272-y","article-title":"Kidney dendritic cells: Fundamental biology and functional roles in health and disease","volume":"16","author":"Kurts","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2017.07.022","article-title":"Renal sodium gradient orchestrates a dynamic antibacterial defense zone","volume":"170","author":"Berry","year":"2017","journal-title":"Cell"},{"key":"B10-20250825","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-020-2424-4","article-title":"Structural cells are key regulators of organ-specific immune responses","volume":"583","author":"Krausgruber","year":"2020","journal-title":"Nature"},{"key":"B11-20250825","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1681\/ASN.2014010117","article-title":"Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis","volume":"25","author":"Anders","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B12-20250825","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.15252\/embj.201488856","article-title":"The good, the bad, and the ugly of interleukin-6 signaling","volume":"33","author":"Fuster","year":"2014","journal-title":"EMBO J"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B14-20250825","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.2007070744","article-title":"IL-6\/IL-6R axis plays a critical role in acute kidney injury","volume":"19","author":"Nechemia-Arbely","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"B16-20250825","doi-asserted-by":"crossref","first-page":"F1043","DOI":"10.1152\/ajprenal.00389.2012","article-title":"Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis","volume":"304","author":"Han","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"B17-20250825","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1681\/ASN.2010030269","article-title":"Macrophages in renal disease","volume":"22","author":"Wang","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B18-20250825","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1681\/ASN.2014060620","article-title":"Inflammation-induced IL-6 functions as a natural brake on macrophages and limits GN","volume":"26","author":"Luig","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12865-018-0261-0","article-title":"Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity","volume":"19","author":"Pavlou","year":"2018","journal-title":"BMC Immunol"},{"key":"B20-20250825","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int"},{"key":"B21-20250825","doi-asserted-by":"crossref","first-page":"19619","DOI":"10.1073\/pnas.1908706116","article-title":"The single-cell transcriptomic landscape of early human diabetic nephropathy","volume":"116","author":"Wilson","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22-20250825","first-page":"1322","article-title":"Macrophages in diabetic nephropathy in patients with type 2 diabetes","volume":"32","author":"Klessens","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B23-20250825","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu Rev Physiol"},{"key":"B24-20250825","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.ackd.2016.11.004","article-title":"Mechanisms of drug-induced interstitial nephritis","volume":"24","author":"Raghavan","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"B25-20250825","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","article-title":"Acute interstitial nephritis: Clinical features and response to corticosteroid therapy","volume":"19","author":"Clarkson","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"B26-20250825","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","article-title":"Biopsy-proven acute interstitial nephritis, 1993\u20132011: A case series","volume":"64","author":"Muriithi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B27-20250825","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.3024","article-title":"Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus","volume":"19","author":"Devi","year":"2013","journal-title":"Nat Med"},{"key":"B28-20250825","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","article-title":"Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes","volume":"289","author":"Suzuki","year":"2014","journal-title":"J Biol Chem"},{"key":"B29-20250825","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int"},{"key":"B30-20250825","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12967-019-02157-2","article-title":"IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy","volume":"17","author":"Peng","year":"2019","journal-title":"J Transl Med"},{"key":"B31-20250825","doi-asserted-by":"crossref","first-page":"697","DOI":"10.6061\/clinics\/2012(07)01","article-title":"Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy","volume":"67","author":"Silva","year":"2012","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"B32-20250825","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"B33-20250825","doi-asserted-by":"crossref","first-page":"e103413","DOI":"10.1371\/journal.pone.0103413","article-title":"The molecular phenotype of endocapillary proliferation: Novel therapeutic targets for IgA nephropathy","volume":"9","author":"Hodgin","year":"2014","journal-title":"PLoS One"},{"key":"B34-20250825","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1172\/JCI94039","article-title":"Neutrophil Fc\u03b3RIIA promotes IgG-mediated glomerular neutrophil capture via Abl\/Src kinases","volume":"127","author":"Nishi","year":"2017","journal-title":"J Clin Invest"},{"key":"B35-20250825","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B36-20250825","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B37-20250825","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00281-013-0375-7","article-title":"Low-density granulocytes: A distinct class of neutrophils in systemic autoimmunity","volume":"35","author":"Carmona-Rivera","year":"2013","journal-title":"Semin Immunopathol"},{"key":"B38-20250825","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imr.12448","article-title":"Human neutrophils in the saga of cellular heterogeneity: Insights and open questions","volume":"273","author":"Scapini","year":"2016","journal-title":"Immunol Rev"},{"key":"B39-20250825","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"B40-20250825","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat Med"},{"key":"B41-20250825","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40560-019-0381-5","article-title":"Neutrophils are a main source of circulating suPAR predicting outcome in critical illness","volume":"7","author":"Gussen","year":"2019","journal-title":"J Intensive Care"},{"key":"B42-20250825","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"B43-20250825","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med"},{"key":"B44-20250825","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm.4362","article-title":"A tripartite complex of suPAR, APOL1 risk variants and \u03b1v\u03b23 integrin on podocytes mediates chronic kidney disease","volume":"23","author":"Hayek","year":"2017","journal-title":"Nat Med"},{"key":"B45-20250825","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2018121227","article-title":"Soluble urokinase plasminogen activator receptor and decline in kidney function in autosomal dominant polycystic kidney disease","volume":"30","author":"Hayek","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B46-20250825","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"B47-20250825","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/dc15-0925","article-title":"Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes","volume":"38","author":"Thomas","year":"2015","journal-title":"Diabetes Care"},{"key":"B48-20250825","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00125-019-4883-4","article-title":"Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes","volume":"62","author":"Wad\u00e9n","year":"2019","journal-title":"Diabetologia"},{"key":"B49-20250825","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1681\/ASN.2018070719","article-title":"Association of soluble TNFR-1 concentrations with long-term decline in kidney function: The multi-ethnic study of atherosclerosis","volume":"29","author":"Bhatraju","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B50-20250825","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2337\/db09-1509","article-title":"Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12-year follow-up study","volume":"59","author":"Nin","year":"2010","journal-title":"Diabetes"},{"key":"B51-20250825","doi-asserted-by":"crossref","first-page":"e0122073","DOI":"10.1371\/journal.pone.0122073","article-title":"Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: A prospective cohort study","volume":"10","author":"Neirynck","year":"2015","journal-title":"PLoS One"},{"key":"B52-20250825","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ekir.2020.12.025","article-title":"The associations of plasma biomarkers of inflammation with histopathologic lesions, kidney disease progression, and mortality-The Boston Kidney Biopsy Cohort Study","volume":"6","author":"Srivastava","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B53-20250825","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrneph.2016.71","article-title":"The role of neutrophils and NETosis in autoimmune and renal diseases","volume":"12","author":"Gupta","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B54-20250825","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"B55-20250825","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B56-20250825","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"M\u00f8ller","year":"2002","journal-title":"Blood"},{"key":"B57-20250825","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2015050511","article-title":"Urinary soluble CD163 in active renal vasculitis","volume":"27","author":"O\u2019Reilly","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B58-20250825","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ndt\/gfy300","article-title":"Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"35","author":"Moran","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B59-20250825","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1681\/ASN.2012070690","article-title":"Onconephrology: The latest frontier in the war against kidney disease","volume":"24","author":"Salahudeen","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B60-20250825","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.484","article-title":"Glomerular diseases seen with cancer and chemotherapy: A narrative review","volume":"84","author":"Jhaveri","year":"2013","journal-title":"Kidney Int"},{"key":"B61-20250825","first-page":"47","article-title":"Onconephrology: The intersections between the kidney and cancer","volume":"71","author":"Rosner","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B62-20250825","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"key":"B63-20250825","doi-asserted-by":"crossref","first-page":"364","DOI":"10.12659\/AJCR.890798","article-title":"A 78-year-old man with acute myeloid leukemia (AML) and acute renal failure","volume":"15","author":"Tapper","year":"2014","journal-title":"Am J Case Rep"},{"key":"B64-20250825","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ekir.2020.12.030","article-title":"Spectrum of kidney involvement in patients with myelodysplastic syndromes","volume":"6","author":"Schwotzer","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B65-20250825","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"B66-20250825","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"B67-20250825","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"B68-20250825","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"B69-20250825","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","article-title":"Clonal haematopoiesis: Connecting ageing and inflammation in cardiovascular disease","volume":"17","author":"Jaiswal","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B70-20250825","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"B71-20250825","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","article-title":"Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis","volume":"3","author":"Cook","year":"2019","journal-title":"Blood Adv"},{"key":"B72-20250825","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"key":"B73-20250825","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp Hematol"},{"key":"B74-20250825","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B75-20250825","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ Res"},{"key":"B76-20250825","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.3324\/haematol.2019.223305","article-title":"Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"105","author":"Arends","year":"2020","journal-title":"Haematologica"},{"key":"B77-20250825","first-page":"1623","article-title":"What to tell your patient with clonal hematopoiesis and why: Insights from 2 specialized clinics","volume":"136","author":"Steensma","year":"2020","journal-title":"Blood"},{"key":"B78-20250825","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000279163","article-title":"Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1 mesangial proliferative glomerulonephritis","volume":"31","author":"Ikezumi","year":"2010","journal-title":"Am J Nephrol"},{"key":"B79-20250825","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","article-title":"Direct effects of dexamethasone on human podocytes","volume":"70","author":"Xing","year":"2006","journal-title":"Kidney Int"},{"key":"B80-20250825","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2012111094","article-title":"Myeloid mineralocorticoid receptor activation contributes to progressive kidney disease","volume":"25","author":"Huang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B81-20250825","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.117.10360","article-title":"Selective mineralocorticoid receptor cofactor modulation as molecular basis for finerenone\u2019s antifibrotic activity","volume":"71","author":"Grune","year":"2018","journal-title":"Hypertension"},{"key":"B82-20250825","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"B83-20250825","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2018.15","article-title":"Angiotensin-converting enzyme in innate and adaptive immunity","volume":"14","author":"Bernstein","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B84-20250825","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.kint.2019.12.014","article-title":"Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model","volume":"97","author":"McAdoo","year":"2020","journal-title":"Kidney Int"},{"key":"B85-20250825","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.4049\/jimmunol.1102603","article-title":"Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients","volume":"189","author":"Kim","year":"2012","journal-title":"J Immunol"},{"key":"B86-20250825","doi-asserted-by":"crossref","first-page":"635188","DOI":"10.3389\/fimmu.2021.635188","article-title":"Neutrophil extracellular traps: A potential therapeutic target in MPO-ANCA associated vasculitis?","volume":"12","author":"O\u2019Sullivan","year":"2021","journal-title":"Front Immunol"},{"key":"B87-20250825","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/sdi.12686","article-title":"Does inflammation affect outcomes in dialysis patients?","volume":"31","author":"Nowak","year":"2018","journal-title":"Semin Dial"},{"key":"B88-20250825","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of interleukin-1\u03b2 by canakinumab and cardiovascular outcomes in patients with chronic kidney disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B89-20250825","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1681\/ASN.2020050595","article-title":"Ziltivekimab for treatment of anemia of inflammation in patients on hemodialysis: Results from a phase 1\/2 multicenter, randomized, double-blind, placebo-controlled trial","volume":"32","author":"Pergola","year":"2021","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.04120321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:47:04Z","timestamp":1786369624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.04120321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04120321","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}